The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would benefit, but it’s doubtful the incoming Trump administration will support it.

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden on Tuesday, increasing access to the widely popular medications to millions of adults with obesity in the U.S., though the plan would likely face opposition under President-elect Donald Trump's second administration.